CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
35 hedge funds and large institutions have $23M invested in Cymabay Therapeutics in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 29 → 35 (+6)
Holders
35
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$3.07M | |
| 2 | +$1.84M | |
| 3 | +$1.62M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.36M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$1.26M |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$1.26M | |
| 3 | -$446K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$97K |
| 5 |
PP
PDT Partners
New York
|
-$75K |